These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35926293)

  • 1. Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement.
    Ahaus P; Schmidt AJ; Skaletz-Rorowski A; Uhrmacher M; Serova K; Kayser A; Wach J; Nambiar S; Brockmeyer NH; Potthoff A
    J Infect Public Health; 2022 Sep; 15(9):955-960. PubMed ID: 35926293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily and event-driven pre-exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence.
    Vuylsteke B; Reyniers T; De Baetselier I; Nöstlinger C; Crucitti T; Buyze J; Kenyon C; Wouters K; Laga M
    J Int AIDS Soc; 2019 Oct; 22(10):e25407. PubMed ID: 31663257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021.
    Marcus U; Schink SB; Weber C
    BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men.
    Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J;
    Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
    AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in Germany.
    Jansen K; Steffen G; Potthoff A; Schuppe AK; Beer D; Jessen H; Scholten S; Spornraft-Ragaller P; Bremer V; Tiemann C;
    BMC Infect Dis; 2020 Feb; 20(1):110. PubMed ID: 32033533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between HIV pre-exposure prophylaxis, sexually transmitted infections, and antimicrobial resistance: a qualitative interview study of men who have sex with men.
    Williams ADN; Wood F; Gillespie D; Couzens Z; Hughes K; Hood K
    BMC Public Health; 2022 Nov; 22(1):2222. PubMed ID: 36447181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study.
    Baltes V; de Boissieu P; Champenois K; Luan L; Seng R; Essat A; Novelli S; Spire B; Molina JM; Goujard C; Meyer L;
    J Int AIDS Soc; 2024 Mar; 27(3):e26226. PubMed ID: 38462760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually transmitted diseases in people living with HIV after implementation of cost coverage of HIV pre-exposure prophylaxis by statutory health insurance in Germany.
    Schuettfort G; Groh A; Kann G; Haberl A; Herrmann E; Wetzstein N; Vehreschild MJGT; Stephan C
    HIV Med; 2023 Feb; 24(2):163-169. PubMed ID: 35859321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort.
    Nozza S; Raccagni AR; Lolatto R; Ceccarelli D; Galli L; Alberton F; Bruzzesi E; Canetti D; Strano M; Ripa M; Bertoni C; Castagna A
    BMJ Open; 2022 Dec; 12(12):e067261. PubMed ID: 36600429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
    Sullivan AK; Saunders J; Desai M; Cartier A; Mitchell HD; Jaffer S; Ogaz D; Chiavenna C; Charlett A; Diamente V; Golombek R; Manavi K; Priestley C; Waters LJ; Milinkovic A; McOwan A; Estcourt C; Sabin CA; Rodger A; Gold D; Gazzard BG; McCormack S; Gill ON;
    Lancet HIV; 2023 Dec; 10(12):e790-e806. PubMed ID: 38040478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands.
    de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M;
    HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-Exposure Prophylaxis Users' Attitudes About Sexually Transmitted Infections and Its Influence on Condom Use: A Mixed-Method Study in Belgium.
    Rotsaert A; Nöstlinger C; Van Landeghem E; Vanbaelen T; Wouters E; Buffel V; Scheerder G; Schim van der Loeff M; Vuylsteke B; Reyniers T
    AIDS Patient Care STDS; 2022 Dec; 36(12):483-492. PubMed ID: 36484763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany.
    Uhrmacher M; Skaletz-Rorowski A; Nambiar S; Schmidt AJ; Ahaus P; Serova K; Mordhorst I; Kayser A; Wach J; Tiemann C; Münstermann D; Brockmeyer NH; Potthoff A
    Front Public Health; 2022; 10():930208. PubMed ID: 36091531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.